T-cell clonotypes in cancer.
Cells of the immune system spontaneously recognize autologous tumor cells and T cells are believed to be the main effector cells for the immune surveillance of cancer. Recent advances in our understanding of basic and tumor immunology together with methodological developments implies that tumor specific T cells can now be studied functionally, phenotypically as well as molecularly. T cells recognize peptide antigens in the context of MHC molecules through the clonally distributed T-cell receptor (TCR), thus, the clonal distribution of the TCR offers the means to detect and track specific T cells based upon detection of the unique TCR. In this review, we present and discuss available data on TCR utilization of tumor specific T cells in murine models as well as spontaneous and treatment induced anti-tumor T-cell responses in humans.
Thor Straten
Per
P
Tumor Immunology Group, Institute of Cancer Biology, Danish Cancer Society, DK-2100 Copenhagen, Denmark. ps@cancer.dk
Schrama
David
D
Andersen
Mads Hald
MH
Becker
Jürgen C
JC